This item is authorised by the following title:
This exemption ends on 31 May 2010, or when the product achieves marketing approval in Australia for the prevention and treatment of anthrax infection in humans, whichever occurs first.
This exemption ends on 31 May 2010, or when the product achieves marketing approval in Australia for the prevention and treatment of anthrax infection in humans, whichever occurs first.